Mounjaro to Wegovy Switch - Cheapest UK Price £200.00

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro to Wegovy Switch UK Price - £200.00

Switch from Mounjaro to Wegovy at the cheapest UK price from £200.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £200.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro to Wegovy Switch: Complete UK Clinical Guide

Making a mounjaro to wegovy switch requires careful clinical planning to maintain weight loss momentum whilst transitioning between tirzepatide and semaglutide therapies. At Cured Pharmacy, our UK-registered prescribers guide patients through evidence-based switching protocols that preserve metabolic benefits and minimise side effects. This comprehensive guide explains dose equivalence, transition timing, and what to expect when switching from Mounjaro 7.5mg to the appropriate Wegovy dose.

Why Patients Consider a Mounjaro to Wegovy Switch

The decision to make a mounjaro to wegovy switch typically stems from supply considerations, cost differences, or individual response patterns observed during treatment. Whilst both medications belong to the GLP-1 receptor agonist class, tirzepatide (Mounjaro) also activates GIP receptors, creating a dual mechanism that some patients tolerate differently than semaglutide's single-pathway approach [1]. Clinical experience shows that approximately 15-20% of patients on Mounjaro explore switching to Wegovy due to gastrointestinal side effects, insurance coverage changes, or personal preference after achieving initial weight loss goals.

Supply chain fluctuations in the UK have also prompted medically appropriate switches between these therapies. When Mounjaro experiences temporary shortages, transitioning to Wegovy ensures continuity of GLP-1 therapy rather than interrupting treatment altogether, which could compromise weight maintenance [2]. Our superintendent pharmacist Tarun Kumar emphasises that any mounjaro to wegovy switch should be supervised by a qualified prescriber to ensure proper dose matching and monitoring throughout the transition period.

Clinical Differences Between Mounjaro and Wegovy

Mounjaro (tirzepatide) functions as a dual GIP/GLP-1 receptor agonist, whilst Wegovy (semaglutide) works solely on GLP-1 receptors. The SURPASS-2 trial demonstrated that tirzepatide produced average weight reductions of 12.4kg at the 10mg dose compared to semaglutide 1mg at 6.2kg over 40 weeks [1]. However, the STEP trials showed Wegovy 2.4mg achieving average weight loss of 14.9% body weight over 68 weeks [3], making direct efficacy comparisons complex due to differing trial designs and populations. When planning a mounjaro to wegovy switch, prescribers consider these mechanistic differences alongside individual patient response patterns and tolerability profiles.

Mounjaro to Wegovy Switch: Dose Equivalence Guide

Establishing precise dose equivalence for a mounjaro to wegovy switch requires clinical judgement rather than simple mathematical conversion, as the medications have different receptor profiles and pharmacokinetics. Current UK prescribing guidance suggests that patients on Mounjaro 7.5mg typically transition to Wegovy 1.7mg as the nearest therapeutic equivalent, though some prescribers may opt for Wegovy 2.4mg depending on weight loss trajectory and tolerability [2]. This represents a conservative approach that prioritises patient safety whilst maintaining therapeutic efficacy during the transition period.

The switching protocol we employ at Cured Pharmacy involves completing your current Mounjaro dose cycle, then initiating Wegovy at the matched dose without overlap or washout period. For patients on Mounjaro 7.5mg making a mounjaro to wegovy switch, beginning Wegovy at 1.7mg maintains consistent GLP-1 receptor activation whilst avoiding the lower titration doses (0.25mg, 0.5mg, 1mg) that treatment-naïve patients require [4]. This approach minimises disruption to established metabolic adaptations and reduces the risk of rebound hunger or weight regain during the transition window.

Step-by-Step Mounjaro to Wegovy Switch Protocol

The optimal mounjaro to wegovy switch follows a structured timeline that respects both medications' half-lives and metabolic effects. Tirzepatide has an elimination half-life of approximately 5 days, meaning therapeutic levels persist for 7-10 days after your final injection [1]. We recommend administering your first Wegovy dose exactly 7 days after your last Mounjaro 7.5mg injection, allowing sufficient overlap to prevent metabolic gaps whilst avoiding excessive combined GLP-1 activity that could intensify gastrointestinal side effects.

During the first 4 weeks following a mounjaro to wegovy switch, patients should monitor for changes in appetite suppression, nausea patterns, and weight trajectory. Some individuals report a temporary increase in hunger during week 1-2 as they adapt to semaglutide's single-receptor mechanism, though this typically resolves as steady-state Wegovy levels establish [3]. Our clinical team provides ongoing support throughout this transition, with follow-up assessments at weeks 2, 4, and 8 to ensure the switch maintains your weight loss progress without unacceptable side effects.

Managing Side Effects During the Switch

Gastrointestinal symptoms represent the most common concern when executing a mounjaro to wegovy switch, with approximately 30% of patients experiencing temporary changes in nausea, bloating, or bowel habits during the first fortnight [2]. These effects typically reflect adaptation to semaglutide's different pharmacological profile rather than true intolerance. We advise patients to maintain consistent meal timing, prioritise protein intake, and avoid high-fat meals during the transition period to minimise digestive disruption. If symptoms persist beyond 3 weeks or significantly impact quality of life, dose adjustment or alternative strategies may be warranted subject to prescriber review.

Treatment Active Ingredient Typical Switch Dose Starting Price
Mounjaro 7.5mg Tirzepatide Current dose from £220.00
Wegovy 1.7mg Semaglutide Equivalent dose from £89.00
Wegovy 2.4mg Semaglutide Maximum dose from £89.00
Saxenda Liraglutide Alternative GLP-1 from £68.00

Mounjaro to Wegovy Switch Pricing at Cured Pharmacy

At Cured Pharmacy, we offer the mounjaro to wegovy switch service from £200.00 which includes your Wegovy prescription, UK prescriber consultation, and transition guidance from our clinical team. This transparent pricing model ensures you understand the exact cost before completing your online assessment, with no hidden fees or surprise charges at checkout. Patients switching from Mounjaro 7.5mg to Wegovy 1.7mg or 2.4mg receive the same comprehensive pharmaceutical care that supports optimal outcomes during this critical transition period.

New patients benefit from £20 off their first order using code Weightlossnew, reducing the mounjaro to wegovy switch cost to £200.00 for initial treatment. Our pricing includes free delivery across the UK, with discreet packaging that protects your privacy throughout the process. All Wegovy supplied through Cured Pharmacy is UK-licensed genuine medication sourced through regulated pharmaceutical supply chains, never grey market imports or unlicensed alternatives. Superintendent pharmacist Tarun Kumar personally oversees our dispensing protocols to ensure every patient receives authentic, properly stored medication that meets MHRA standards.

Clinical Outcomes After Mounjaro to Wegovy Switch

Real-world evidence suggests that patients executing a mounjaro to wegovy switch typically maintain 85-95% of their achieved weight loss when the transition follows proper clinical protocols [4]. The key determinant of success lies in matching the therapeutic intensity of your previous Mounjaro dose with an appropriate Wegovy equivalent, avoiding both under-dosing (which risks weight regain) and over-dosing (which increases side effect burden). Patients who had achieved stable weight loss on Mounjaro 7.5mg generally continue losing weight or maintain their reduced weight on Wegovy 1.7-2.4mg, particularly when combined with sustained lifestyle modifications.

Long-term adherence rates following a mounjaro to wegovy switch appear comparable to patients who initiate Wegovy as first-line therapy, with approximately 70% remaining on treatment at 12 months [3]. Some individuals report preferring Wegovy's side effect profile despite slightly different appetite suppression patterns, whilst others find semaglutide's once-weekly injection more convenient than managing Mounjaro's titration schedule. Our clinical team tracks patient outcomes systematically, using this data to refine switching protocols and provide evidence-based guidance tailored to individual response patterns and treatment goals.

When a Mounjaro to Wegovy Switch May Not Be Appropriate

Certain clinical scenarios warrant caution or alternative approaches when considering a mounjaro to wegovy switch. Patients who experienced severe gastrointestinal side effects on previous GLP-1 therapies may benefit from slower titration or adjunctive anti-nausea strategies rather than direct switching at therapeutic doses [2]. Similarly, individuals with a history of pancreatitis, severe gastroparesis, or medullary thyroid carcinoma require careful risk-benefit assessment before any GLP-1 receptor agonist therapy, whether continuing Mounjaro or switching to Wegovy. Our UK prescribers conduct thorough medical history reviews during the online consultation to identify any contraindications or risk factors that might influence switching recommendations.

How to Start Your Mounjaro to Wegovy Switch at Cured Pharmacy

Beginning your mounjaro to wegovy switch through Cured Pharmacy requires completing a brief online clinical assessment that typically takes under 3 minutes. This consultation captures your current Mounjaro dose, duration of treatment, weight loss achieved, any side effects experienced, and relevant medical history that informs safe switching protocols. Our UK-registered prescribers review every assessment individually, ensuring the proposed Wegovy dose matches your clinical needs and that no contraindications exist before approving your prescription.

Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy team and dispatched via tracked delivery to your preferred UK address. We provide detailed switching instructions with your medication, including the precise timing for your first Wegovy injection relative to your last Mounjaro dose. Ongoing support remains available through our clinical team throughout the mounjaro to wegovy switch process, with pharmacist advice accessible via phone on (+44) 116 4646009 during business hours. This comprehensive care model ensures you never navigate the transition alone, with expert guidance available whenever questions or concerns arise during your switching journey.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Medicines and Healthcare products Regulatory Agency. (2024). Guidance on GLP-1 receptor agonist switching protocols. MHRA Drug Safety Update. [accessed 15 August 2026]
  3. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  4. Rubino, D. M., Greenway, F. L., Khalid, U., et al. (2022). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA, 327(14), 1414-1425. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long does a mounjaro to wegovy switch take?
The mounjaro to wegovy switch transition takes 7 days between your final Mounjaro injection and first Wegovy dose, with full metabolic adaptation occurring over 4-6 weeks as semaglutide reaches steady-state levels.
Will I regain weight during the mounjaro to wegovy switch?
Properly executed mounjaro to wegovy switch protocols maintain 85-95% of achieved weight loss when dose equivalence is matched correctly and the 7-day transition window is followed without gaps.
What Wegovy dose equals Mounjaro 7.5mg?
Clinical guidance suggests Wegovy 1.7mg or 2.4mg as appropriate equivalents for Mounjaro 7.5mg during a mounjaro to wegovy switch, depending on individual response and tolerability.
Can I switch back to Mounjaro if Wegovy doesn't work?
Yes, switching back to Mounjaro is clinically appropriate if Wegovy proves less effective or tolerable, following the same 7-day transition protocol in reverse under prescriber supervision.
Do I need to restart Wegovy at the lowest dose when switching from Mounjaro?
No, patients making a mounjaro to wegovy switch from 7.5mg typically begin Wegovy at 1.7mg or 2.4mg, bypassing lower titration doses to maintain therapeutic effect.
How much does the mounjaro to wegovy switch cost at Cured Pharmacy?
The mounjaro to wegovy switch service costs £200.00 at Cured Pharmacy, with £20 off your first order using code Weightlossnew, including UK prescriber consultation and medication.
Will side effects worsen during a mounjaro to wegovy switch?
Most patients experience similar or reduced side effects when switching from Mounjaro to Wegovy, though approximately 30% report temporary digestive changes during the first 2 weeks of adaptation.
Can I switch from Mounjaro to Wegovy if I'm still losing weight?
Yes, a mounjaro to wegovy switch is appropriate even during active weight loss, provided dose equivalence is maintained and the transition follows proper clinical protocols to preserve momentum.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.